Treatment of paediatric Hodgkin's disease. a balance of risks

Eur J Cancer. 2002 Mar;38(4):468-77. doi: 10.1016/s0959-8049(01)00335-5.

Abstract

Hodgkin's disease is one of the commoner malignancies presenting in adolescence and young adulthood and is curable in the majority of cases. A number of therapeutic regimens have been used successfully, often at the expense of the development of side-effects in later life, including second malignancies, infertility and cardiac disease. We discuss the challenge faced by paediatric oncologists today in finding the balance between maximising cure and minimising the late effects.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Child
  • Child, Preschool
  • Female
  • Growth Disorders / chemically induced
  • Heart Diseases / chemically induced
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / radiotherapy*
  • Humans
  • Infant
  • Infertility, Male / chemically induced
  • Male
  • Primary Ovarian Insufficiency / chemically induced
  • Radiotherapy / adverse effects
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Thyroid Diseases / chemically induced
  • Time